azauridine has been researched along with Akinetic-Rigid Variant of Huntington Disease in 1 studies
Azauridine: A triazine nucleoside used as an antineoplastic antimetabolite. It interferes with pyrimidine biosynthesis thereby preventing formation of cellular nucleic acids. As the triacetate, it is also effective as an antipsoriatic.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, N | 1 |
| Wu, YY | 1 |
| Feng, Y | 1 |
| Hsieh, WC | 1 |
| Song, JS | 1 |
| Lin, YS | 1 |
| Tseng, YH | 1 |
| Liao, WJ | 1 |
| Chu, YF | 1 |
| Liu, YC | 1 |
| Chang, EC | 1 |
| Liu, CR | 1 |
| Sheu, SY | 1 |
| Su, MT | 1 |
| Kuo, HC | 1 |
| Cohen, SN | 1 |
| Cheng, TH | 1 |
1 other study available for azauridine and Akinetic-Rigid Variant of Huntington Disease
| Article | Year |
|---|---|
Chemical interference with DSIF complex formation lowers synthesis of mutant huntingtin gene products and curtails mutant phenotypes.
Topics: Alleles; Animals; Azauridine; Cells, Cultured; Disease Models, Animal; DNA Repeat Expansion; Drosoph | 2022 |